ENABLES FORTUNE 250 CLIENTS ACROSS INDUSTRIES

Highlights of multiple projects for a Fortune 75 pharma company:

• Leading the development of RAI knowledge banks & deployment strategy. Won the next phase of the project, which commences in 2025. NPS Score: 10/10.

• Co-led the Next Best Experience (NBX) discovery until strategic recommendations.

• Led the identification of gaps & recommendation of solutions for onboarding & training processes for select stakeholders.

• Led the redesign of the confluence pages to enhance usability & increase user adoption. 

• Co-led the development of a vaccine hesitancy measurement dashboard for marketeers.

Behavior design lead on deal modeling application tool development for a Fortune 10 pharma distribution company. Co-led the interactive demo that was developed, which enabled acquiring the project.

Behavior design lead for a data & analytics roadmapping project & design BI dashboard solutions to drive adoption for a Fortune 250 pharma & payer company. Led the creation & development of a centralized toolkit of frameworks & tools contextualized to roadmapping projects to enable other engagements to streamline future business delivery.

Highlights of multiple projects for a Fortune 100 pharma company:

• Behavior design advisor on the design development of a batch analyzer feature for a vaccine plant.

• Behavior design lead for the design & development of reimagining negotiation through automation & intelligent procurement insights.

Co-led the development of a strategy for a Fortune 200 Pharma company to create seamless patient journeys, understand patient needs, hyper-personalize interventions, & anticipate future behavior for diabetes patients.

Co-led the development of identifying impactful touchpoints along the consumer/shopper journey (VMS & Pain) that could be leveraged to drive growth & conversion for a Fortune 200 Pharma company.

Led a research study on Digital Health Adoption to understand various perspectives & deploy holistic solution programs to create value for consumers & intermediaries in digital care for payers in the US healthcare system.

Developed strategic recommendations for a Fortune 75 pharma company to improve patients' onboarding experience & long-term adherence. Additionally, to efficiently integrate the recommended solutions into existing infrastructure, & patient support. Project was executed in the US, UK, & France.

Led the behavioral development & strategic recommendations for understanding drivers of nurse attrition & retention through primary & secondary research, develop reliable predictive models to forecast attrition with an objective of assessing the ROI of interventions & build near-term & long-term strategies to identify root causes for attritions & address them holistically for a leading US Provider.

Led a Behavior Architecture focussed initiative for Population Health & converted it into a centralized visual knowledge repository. Advisors included leading population health experts.